已收盤 10-24 16:00:00 美东时间
+0.020
+0.96%
Daré Bioscience, Inc. (NASDAQ:DARE), a biopharmaceutical company with a sole focus of closing the gap in women's health between promising science and real solutions, today announced it has entered into an agreement with
09-24 20:04
Daré Bioscience has partnered with the Gates Foundation to receive up to $499,000 for mentorship and project management support in addressing preeclampsia, a leading cause of maternal and infant death with no FDA-approved treatments. The collaboration aims to enhance the impact and sustainability of research projects focused on preventing, diagnosing, and treating this critical but underserved condition in maternal care.
09-24 12:00
炒股就看金麒麟分析师研报,权威,专业,及时,全面,助您挖掘潜力主题机会! (来源:网易科技) 在九月山寨币(memecoin)热潮的推动下,基于Sola...
09-18 14:44
Analysts are intrested in these 5 stocks: ( ($DARE) ), ( ($AMD) ), ( ($TWLO) ),...
09-06 17:01
Top Wall Street analysts changed their outlook on these top names. For a comple...
09-04 22:05
Maxim Group analyst Caroline Palomeque upgrades Dare Bioscience (NASDAQ:DARE) from Hold to Buy and announces $8 price target.
09-04 20:12
Dare Bioscience (NASDAQ:DARE) reported quarterly losses of $(0.45) per share which beat the analyst consensus estimate of $(0.61) by 26.83 percent. This is a 129.61 percent decrease over earnings of $1.52 per share from
08-15 04:03
Companies Reporting Before The Bell • Sunlands Technology (NYSE:STG) is likely ...
08-14 16:32
Dare Bioscience (NASDAQ:DARE) is set to give its latest quarterly earnings repo...
08-14 00:02
Daré Bioscience will host a conference call on August 14, 2025, at 4:30 p.m. ET to discuss its Q2 2025 financial results and provide an update. The call can be accessed via phone (646-307-1963 or 800-715-9871) with conference ID 2684883, or via live webcast at ir.darebioscience.com. The company, focused on women’s health, has several innovative products in development, including XACIATO for bacterial vaginosis, Ovaprene for contraception, Sildena...
08-07 12:00